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Abstract
Background: The normalization of DNA microarrays allows comparison among samples by
adjusting for individual hybridization intensities. The approaches most commonly used are global
normalization methods that are based on the expression of all genes on the slide and on the
modulation of a small proportion of genes. Alternative approaches must be developed for
microarrays where the proportion of modulated genes and their distribution are unknown and they
may be biased towards up- or down-modulated trends.
Results: The aim of the work is to study the use of spike-in controls to normalize low-density
microarrays. Our test-array was designed to analyze gene modulation in response to hypoxia (a
condition of low oxygen tension) in a macrophage cell line. RNA was extracted from controls and
cells exposed to hypoxia, mixed with spike RNA, labeled and hybridized to our test-array. We used
eight bacterial RNAs as source of spikes. The test-array contained the oligonucleotides specific for
178 mouse genes and those specific for the eight spikes. We assessed the quality of the spike
signals, the reproducibility of the results and, in general, the nature of the variability. The small
values of the coefficients of variation revealed high reproducibility of our platform either in
replicated spots or in technical replicates. We demonstrated that the spike-in system was suitable
for normalizing our platform and determining the threshold for discriminating the hypoxia
modulated genes. We assessed the application of the spike-in normalization method to microarrays
in which the distribution of the expression values was symmetric or asymmetric. We found that
this system is accurate, reproducible and comparable to other normalization methods when the
distribution of the expression values is symmetric. In contrast, we found that the use of the spike-
in normalization method is superior and necessary when the distribution of the gene expression is
asymmetric and biased towards up-regulated genes.
Conclusion:  We demonstrate that spike-in controls based normalization is a reliable and
reproducible method that has the major advantage to be applicable also to biased platform where
the distribution of the up- and down-regulated genes is asymmetric as it may occur in diagnostic
chips.
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Background
Studies on gene expression rely heavily on DNA microar-
ray technology [1]. In a typical microarray experiment, the
two RNA samples to be compared are reverse transcribed
in cDNA, labeled using two different fluorophores and
then hybridized simultaneously to the glass slide to meas-
ure the relative gene expression level [2]. Essential to the
analysis of microarray data is the normalization process,
which allows comparison among samples by adjusting for
individual hybridization intensities. There are many
approaches to normalize expression levels and the most
commonly used, referred to as global normalization
methods, apply to experiments in which most of the genes
are equally expressed in both channels [3]. The global
normalization approach is based on the use of the major-
ity of genes on the slide to normalize microarray experi-
ments and a constant adjustment is used to force the
distribution of signal ratios to have the same measure of
central tendency, e.g., the same median. These methods
can be applied when the elements spotted on the array are
representative of a random and large number of genes [4]
and when there is symmetry in the frequency of the up/
down-regulated genes [5]. Alternative approaches have to
be developed when the majority of the genes represented
on the array are coordinately up- or down-modulated as
in the case of diagnostic chips [3,6]. Diagnostic chips are
designed as low-density microarrays containing a number
of selected genes expected to be concomitantly up- or
down-regulated in response to given signals, drugs, or
pathological conditions. The advantage of low-density
over high-density platforms is the competitiveness in
price and the flexibility of design.
We propose the use of external reference RNAs (also
known as spike-in controls or spikes) to normalize the
data of low-density microarray. Spike RNAs show no
sequence similarity to the genome of the studied species
and they are added in defined amounts to experimental
RNA samples before labeling. The oligonucleotides spe-
cific for the spike RNAs are spotted onto the slide. The use
of spikes allows not only data normalization but also the
evaluation of several parameters of the platform quality,
including the sensitivity and specificity of the microarray
experiments, the accuracy and reproducibility of the
measurements and the assessment of technical variability
introduced by labeling procedure, hybridization and
image scanning [7,8].
Our laboratory is involved in the study of the cellular
response to hypoxia, a condition of low oxygen tension
that characterizes many pathological situations [9].
Hypoxia occurs in cardiovascular, hematological, and pul-
monary disorders, inflammatory processes, and fibrosis
[10]. Areas of low oxygen concentration are present in
solid tumors and are known to contribute to tumor
growth, metastasis, and resistance to radio and chemo-
therapy [11]. We and others have applied microarray tech-
nology to define the profile of gene expression associated
to hypoxia utilizing the Affymetrix GeneChip [12] and we
are in the process of designing low-density microarrays
that will identify the hypoxia-inducible genes in tumor
specimens, and may serve as prognostic indicators of the
aggressiveness of the disease and of the sensitivity to ther-
apy. A prerequisite for the development of such tool is a
correct normalization procedure and a sound analysis of
the data that does not require preexisting information on
the expected pattern of results and that will be suitable
even if the majority of the genes is modulated or the dis-
tribution of up- or down-regulated genes is asymmetric.
In this study, we demonstrate that a composite loess nor-
malization [13,14] based on spike-in controls is the
proper way to deal with low-density microarray platforms
that applies also to extreme distribution of the data when
the global normalization approaches will generate errone-
ous results.
Results and discussion
Experimental planning
We describe a normalization/validation procedure of a
low-density array (test-array) based on spike-in controls
(spike RNA). The spike RNA consists of eight, commer-
cially available, purified bacterial mRNAs with no similar-
ity to the mouse genome (Table 1). The corresponding 50
mers were spotted on the test-array which contains a total
of 48 replicates of each spike printed by 4 different pins
and distributed on the slide as described in the Methods
section. The experiments were aimed at evaluating spike
signals when variable amounts of spike RNA are added to
experimental RNA and hybridized to the test-array. Exper-
imental RNA was purified from the murine macrophage
cell line ANA-1 [15] that was cultured in a normoxic or
hypoxic environment for 18 hrs in order to define the
hypoxia inducible genes. Experimental RNA from nor-
moxic and hypoxic macrophages was spiked with the
eight different spike RNAs. The samples were labeled with
red and green fluorophores, mixed, hybridized to the test-
array and tested for fluorescence signals. The oligonucle-
otides spotted on the test-array represented 178 mouse
genes induced- or inhibited- by hypoxia or by other stim-
uli and those specific for the spike RNAs. Rough data were
filtered on the bases of the signal and only signals with
more than 50% of the pixels falling two standard devia-
tions over the local background were considered for the
analysis. This filtering procedure, described by Bahler et al.
[16], discarded unreliable data coming from weak signals,
caused by nonspecific hybridization, and retained those
in which at least half of the spot was significantly brighter
than the background. Whenever a spot did not pass this
criterion for one channel but in the other channel hadBMC Genomics 2007, 8:17 http://www.biomedcentral.com/1471-2164/8/17
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more than 95% of the pixels satisfying the inclusion crite-
ria, the spot was included in the analysis. The reason for
this procedure was the effort of including in the analysis
genes weakly expressed in one experimental condition but
with reliable expression in the other [16].
Spikes' signal
Initial experiments were performed to characterize the sig-
nals of the spike RNA in the biological setting. Experimen-
tal RNA from control and hypoxia treated macrophages
were mixed with equal amounts of each spike RNA gener-
ating an expected ratio of 1 in the spike signal. The exper-
iments were designed in such a way that each pin printed
quadruplicate subarrays containing the entire set of eight
oligonucleotides corresponding to the spikes and one
fourth of the oligonucleotides specific for the experimen-
tal genes.
The first issue that we addressed was the reproducibility of
the signal of the spike RNA. We calculated the coefficient
of variation (CV) for each spike on the 48 replicates
present on each individual test-array and we averaged the
CV and standard deviations (SD) of seven independent
test-arrays analysed (Table 2). We found that the CV
ranged from 5.15% to 8.10% depending on the spike,
indicating low variation and a good level of reproducibil-
ity of the results similar to what described for other plat-
forms [16,17]. This conclusion was supported by the
analysis of the standard deviations that were quite homo-
geneous and ranged from 0.05 and 0.11.
Analysis of variance (ANOVA) was used to estimate the
contribution of each potential source of error to the over-
all variability. For this purpose, several pairs of experi-
mental RNA from control or hypoxic macrophages were
mixed with increasing amounts of the eight spike RNAs
(10, 250, 750, 1000 pg) each of which generated an
expected ratio of 1. The ANOVA explored the association
between the log ratio of all spikes and the potential
sources of variance including spike characteristics
(genomic sequence, base composition, length of the
mRNA, interaction with the other RNA in the sample,
etc.), mRNA spike concentration, position on the array
(spot size, tips, slide homogeneity, printer accuracy, etc.),
and interaction term between the spike characteristics and
spike concentration. The results are shown in Table 3 in
the "Before normalization" panel. We found that the
major portion of the variability could be attributed to the
spike concentration (48.3%) followed by the interaction
term (29.7%), and the spike characteristics (17.8%). The
Table 1: RNA spikes: length and base composition
RNA spike Length (nt) Base Compositiona)
CUAG
sp 1 750 23.5% 26.5% 21.9% 28.1%
sp 2 752 29.7% 23.5% 20.6% 26.2%
sp 3 1000 23.2% 25.9% 16.6% 34.3%
sp 4 1000 23.5% 22.0% 27.0% 27.5%
sp 5 1034 27.5% 22.3% 22.8% 26.4%
sp 6 1250 27.7% 21.8% 22.3% 28.2%
sp 7 1474 27.9% 20.5% 24.4% 27.3%
sp 8 2000 27.2% 21.4% 23.7% 27.8%
a) Expressed as percentage of the base with respect to the total nucleotide content
Table 2: Reproducibility of replicate spots within array
Spike SDa) CVb)
sp 1 0.08 5.15%
sp 2 0.05 5.57%
sp 3 0.08 6.91%
sp 4 0.07 6.40%
sp 5 0.11 6.25%
sp 6 0.06 5.50%
sp 7 0.07 7.13%
sp 8 0.08 8.10%
a)Standard deviation (SD) of M-values (M = log2R-log2G) was calculated for each series of 48 replicate spots within array. The averages of the SD of 
seven independent microarray experiments are shown. b) Coefficient of variation (CV) [(SD of M-values × 100)/mean of M-values] was calculated on 
the same sets of data and the averages of the seven independent microarray experiments are shown.BMC Genomics 2007, 8:17 http://www.biomedcentral.com/1471-2164/8/17
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position on the array did not seem to contribute signifi-
cantly to the variability of the system (0.4%), in contrast
to what observed in other platforms [5].
The difference between the observed ratios of the various
spikes and the expected ratio of 1 was rather small but
occasionally some outlier spikes were far from 1. We
explored the possibility to reduce the variability eliminat-
ing outlier values. Outliers were defined as those spikes
showing either great variability among replicates or ratios
far from 1. We developed a filtering procedure to keep the
spikes that showed low variability, defined as CV less than
10%[18], and a mean ratio falling 1 ± two standard devi-
ations to exclude values in the extreme 5% of the distribu-
tion. Table 4 shows the results of one experiment in which
we utilized the data of the seven independent microarray
experiments used to calculate the reproducibility shown
in Table 2. The mean ratios and standard deviations of the
eight spikes within each experiment were calculated and
the outliers were removed using the above criteria. The
results demonstrated that some spikes were very repro-
ducible and did not generate any outlier. In some
instances one or two outliers out of seven replicates (Table
4) were detected and excluded from the analysis of the
data. After the removal of the outliers a significant
decrease in the CV was observed demonstrating the value
of the filtering procedure.
In summary, these results clearly show that the informa-
tion provided by spikes' signal is reproducible, character-
ized by low variability (that can be further reduced by
filtering our outliers values) and suitable to normalize the
results of our test-array.
Normalization of the spikes' signal
The relative fluorescence intensity between channels must
be normalized to adjust for systematic biases such as dif-
ferences in RNA levels, dye incorporation and detection
efficiencies [13]. The dye balance may vary with spot
intensity and with spatial position on the array. Loess and
Table 3: ANOVA analysis before and after normalization
Before normalization After normalization
Source of variationa) sum of squares degree of freedom p-value % of variance sum of squares degree of freedom p-value % of variance
Spike concentrationb) 169.084 3 0.000 48.3% 0.762 3 0.000 1.0%
Spike characteristicsc) 62.295 7 0.000 17.8% 50.094 7 0.000 40.4%
Array positiond) 1.530 11 0.000 0.4% 1.247 11 0.000 0.6%
Concentration* characteristicse) 104.040 21 0.000 29.7% 58.848 21 0.000 47.4%
Errorf) 13.477 1240 3.8% 13.105 1240 10.6%
Totalg) 332.992 1282 119.280 1282
R Squaredh) = 0.958 R Squaredh) = 0.887
a) The variability is subdivided into independent variances. b) Amount of spikes in the experiment. c) Base composition, length of the mRNA and 
interaction with other RNA molecules. d) Spot size, tips, slide homogeneity, printer accuracy. e) Interaction between spike concentration and spike 
characteristics. f) Residual variability. g) Corrected total variability. h) R squared calculated from linearity test resulting from the amount of variance in 
the dependent variable that is accounted for by the corrected model.
Table 4: Variability of spike after excluding outlier values
Before exclusion After exclusion
Spike CV a) CV b) Excluded c)
sp1 5.15% 4.85% 14% (1/7)
sp2 5.57% 5.57% 0
sp3 6.91% 6.31% 14% (1/7)
sp4 6.40% 6.40% 0
sp5 6.25% 4.80% 29% (2/7)
sp6 5.50% 5.50% 0
sp7 7.13% 6.48% 14% (1/7)
sp8 8.10% 6.47% 29% (2/7)
a)Coefficient of variation (CV) [(SD of M-values × 100)/mean of M-values] was calculated for each series of 48 replicate spots within array before 
the outliers exclusion. The averages of the seven independent microarray experiments are shown. b) Coefficient of variation (CV) after the 
exclusion procedure. The CV was calculated as the mean of the remaining data after the filter. c) Percentage of experiments in which the single spike 
was excluded on a total of seven experiments. The number of experiments in which the specific spike was excluded out of the seven arrays 
analyzed is shown in parenthesis.BMC Genomics 2007, 8:17 http://www.biomedcentral.com/1471-2164/8/17
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print-tip loess normalization are among the most com-
monly used methods to remove such variability although
the application of this algorithm is not free from potential
risk on the interpretation of the results [5,14]. We utilized,
as a routine, the loess normalization procedure, which
does not take into consideration the tip-to-tip variability
because, under the present experimental conditions, the
ANOVA showed that the contribution of the position on
the array to the total variability were negligible.
We applied a composite loess normalization to the spikes'
signal [14], which corrects the expression log-ratios for
intensity-based trends by subtracting from each expres-
sion log-ratio the corresponding value of the loess curve.
The loess curve is constructed exclusively on the spike-in
controls expression data and it is not biased by experi-
mental genes values [13,14]. Being R and G the back-
ground-corrected red and green intensities for each spot
respectively, the expression log-ratio (M-value) corre-
sponding to a generic spot is M = log2R - log2G, whereas
the log-intensity (A-value) of each spot is defined as A =
(log2R+log2G)/2. The effect of normalization on the dis-
tribution of the ratios of the spikes in four independent
measurements is shown in the box-plots in Figure 1.
Before normalization (Figure 1A) the values are dispersed
around the theoretical value of zero, but following loess
normalization (Figure 1B) the spreading was clearly
diminished providing further evidence of the need for
normalization in comparing different experiments.
To define the effects of normalization on the variability
the spikes' signal data were analyzed by ANOVA (Table 3,
"After normalization") and compared to those obtained
in the absence of normalization ("Before normaliza-
tion"). When dissecting such variability into its compo-
nents we found a major decrease for the spike
concentration (from 48.3% to 1%) indicating that any
spike concentration within the range from 10 to 1000 pg
could be used, including low amounts of spike with a sub-
stantial saving of reagents.
The normalization did not affect the variability associated
to the array position, and most variability is now
explained by the spike characteristics (40.4%) or by their
interaction with the spike concentration (47.4%). The lit-
tle change in the R squared between the two ANOVA
models (from 0.958 to 0.887) is due to the change in the
relationship between the components and the interaction
term and it does not affect the reliability of the model.
Comparison among different experimental arrays may
require a scalarization of the data following normaliza-
tion to adjust for dyes unbalance. We assessed the possi-
bility of a further improvement of the data consequent to
the spike signals scalarization. Figure 2 shows the empiri-
cal cumulative distributions (ECDs) of the standard devi-
ations for M-values on four technical replicates in which
data were not normalized (blue line), normalized but not
scaled (red line), normalized and scaled through the quan-
tile method (green line) [19], or normalized and scaled
through the scale method (black line) [3,5,14]. The shift of
the blue line confirms the importance of normalization of
the results. The red, green and black lines are almost
superimposed showing that the scaling process does not
provide any practical improvement in terms of standard
deviation of M-values. The small deviations of the black
and green line curves from the red one suggest that the
noise introduced by the scaling may be more detrimental
than a small difference in scale. We conclude that spike
signal normalization is a necessary step for subsequent
use as internal reference whereas scaling is not required.
Analysis of the experimental platform using the spikes
Having identified experimental conditions for optimal
analysis of the spikes' signal, we studied the experimental
RNA expression values following spike-in based normali-
zation. The loess normalization based on spike-in con-
trols corrects the whole set of expression data constructing
a loess curve on spikes log-ratios. The experimental RNA
log-ratios are corrected for intensity-based trends subtract-
ing from each expression log-ratio the corresponding
value of the loess curve [14]. The normalized results of
four replicate experiments in which we added 250 pg of
spike RNA to the experimental RNA are represented as box
plots in Figure 3A. A variation of the spread and of the
alignment among replicate experiments is evident sug-
gesting the need for scaling to compare the results. After
scaling with the quantile method [19] (Figure 3B) a good
alignment and a similar spread can be demonstrated indi-
cating that scaling is important for the experimental data
although not needed for the spikes themselves as previ-
ously discussed. The variability of the experimental data
following normalization and scaling is measured by cal-
culating the standard deviations (SD) and the coefficient
of variations (CV) of the signal from spikes and experi-
mental genes among replicate arrays (technical repeats)
(Figure 4). The variability of the technical repeats meas-
ured on spikes' signal (Figure 4, left side) was very similar
to that calculated on experimental genes (Figure 4, right
side) indicating a high degree of reproducibility of the
platform.
Quantitative spiking experiments were carried out to
determine the sensitivity of the system. Increasing
amounts of spike (ranging from 5 to 5000 pg) were added
into a sample of 15 μg of experimental RNA (Figure 5).
We found that the signal readout was linear over the entire
range of concentrations. The detection limit was at a dilu-
tion of 1:150,000 (w/w), which corresponds approxi-
mately to 5 pg of specific mRNA.BMC Genomics 2007, 8:17 http://www.biomedcentral.com/1471-2164/8/17
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To define the theoretical cut-off ratio identifying regulated
genes, we calculated the ROC curve [20] on the values
obtained in experiments in which spikes were added at
pre-defined amounts to obtain ratios of 1 (500/500 pg),
1.5 (750/500 pg), 2 (1000/500 pg) and 3 (1500/500 pg).
Dye swap was performed to generate reverse ratios. The
results are shown in Figure 6 where the true positive rate
(sensitivity) is plotted against the false positive rate (1-
specificity) for the different thresholds applied. We
defined the genes with ratios = 1.5, 2, 3 as positive and
genes with ratio = 1 as negative. ROC curve analysis was
performed comparing the distribution of positive versus
negative genes. The ROC curve indicates that 1.26 is the
best cut-off ratio to discriminate regulated genes from
Box plots of the expression log-ratios (M-values) of spike genes of four replicates (r1–r4) Figure 1
Box plots of the expression log-ratios (M-values) of spike genes of four replicates (r1–r4). Each box corresponds to one array 
where the amount of spike RNA on both channels is 250 pg. (A) Box plots before normalization (i.e. only background sub-
tracted M-values of raw data). (B) Box plots after normalization (i.e. loess normalized M-values).
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non-regulated genes, with a sensitivity (true regulated
genes) of 89.7%, a specificity (true non-regulated genes)
of 97.8% and a rate of genes correctly classified of 93.3%.
According to our experimental system, 1.26 is the ratio
corresponding to the point on the ROC curve nearest to
the left-hand corner, representing the highest theoretical
value of accuracy (probability of correct classification =
100%). The ratio of 1.74 resulted in 100% of probability
to classify true regulated genes since above this ratio the
false positive rate is equal to zero. We conclude that genes
showing ratios above 1.74 are definitively up-regulated
and below 1.26 are definitively non-regulated. The choice
of thresholds at intermediate levels will be dictated by the
nature of the experiment and the required stringency that
can be deduced from the ROC table. Efficient normaliza-
tion using the loess curve requires that the platform man-
Empirical Cumulative Distributions (ECDs) of standard deviation of the M-values for spikes on loess-normalized data (red line),  loess normalized and scaled via the quantile method (green line), loess normalized and scaled via the scale method (black line)  and raw data (blue line) on seven technical replicates Figure 2
Empirical Cumulative Distributions (ECDs) of standard deviation of the M-values for spikes on loess-normalized data (red line), 
loess normalized and scaled via the quantile method (green line), loess normalized and scaled via the scale method (black line) 
and raw data (blue line) on seven technical replicates. The graph shows the frequency (Y-axis) of the standard deviation of the 
M-values (X-axis). As a term for comparison, we provide the values of the median standard deviations corresponding to the 
ECDs: red = 0.18, green = 0.19, black = 0.20, blue = 0.36.
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ifests specific characteristics in terms of spike properties
and number of replicates. The first requirement is that the
intensities of the signals of the various spikes span across
the range of intensities of the experimental data [19]. The
relationship between our experimental data and the eight
spikes used is shown in Figure 7. The spike-in controls
have a range of log-intensities spanning between 8 and
13, which comprises 75% of the 178 expression data.
Such differences of log-intensity among spikes are caused
by intrinsic characteristics including base composition,
length of the mRNA and interaction with other RNA mol-
ecules, and they are unpredictable and must be verified for
Box plots of the M-values on four technical replicates (r1–r4) for normalized experimental genes Figure 3
Box plots of the M-values on four technical replicates (r1–r4) for normalized experimental genes. The amount of spike RNA 
on both channels is 250 pg. (A) Box plots before scaling. (B) Box plots after the quantile scale method.
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each set of spikes. In our situation, the spikes were suita-
ble for normalization without further adjustments. Modi-
fication of the spike concentration and/or the number of
spikes used must be considered in the event of a partial
coverage of the range of intensities of the experimental
data by the spikes' signal.
A second consideration is the strength of the loess curve
with respect to the number of replicates. We calculated the
minimum number of replicates needed to have a robust
loess procedure. The robustness was calculated on the
basis of reproducibility of the normalized data consider-
ing an increasing number of replicates and we set as a
Array data reproducibility Figure 4
Array data reproducibility. (A) The histograms represent the distribution of the standard deviations (SD) of M-values of tech-
nical repeats for the spikes (left side) and for the experimental genes (right side). The mean SDs of the repeated measurements 
of each group are shown. (B) The histograms represent the distribution of the coefficients of variation (CV) [(SD of M-values 
× 100)/mean of M-values] of technical repeats for the spikes (left side) and for the experimental genes (right side). The mean 
CVs of all repeated measurements of each group are shown.BMC Genomics 2007, 8:17 http://www.biomedcentral.com/1471-2164/8/17
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threshold for our system a CV of 10%. In our platform we
have 8 spikes each replicated 48 times in each slide for a
total of 384 replicates. We applied a Monte Carlo resam-
pling procedure aimed at sampling 100 times the 384 rep-
licates collecting randomly each time a fixed number of
replicates (n < 384). Each sample was used for normaliza-
tion of the array, the mean expression value of the experi-
mental data was computed and the CVs based on each
sample were calculated (data not shown). We found that
the CV was less than 10% when the number of replicates
was equal or greater that 200 and we concluded that a
minimum of 200 replicates is needed for an accurate nor-
malization of the platform. In our platform we spotted 48
replicates per spike and, theoretically, five spikes would be
sufficient to reach the threshold number of 200 replicates.
However, this is the minimum number required and five
spikes would not allow, for example, the elimination of
the outliers. On the bases of our limited experience, we
propose that a platform that uses the spike-in normaliza-
tion system, as that described here, must adhere to the
requirement of a minimum of 200 replicates among all
spikes and a set of spikes representative of the range of
expression values of the experimental data. In general, the
optimal number of spikes/replicates to be used will have
to be calculated considering the range of log-intensities
covered by the spikes and the reproducibility of the nor-
malized data with an increasing number of replicates.
Normalization and scaling of the experimental platform
One purpose for developing this spike-in controls plat-
form is the possibility of applying this methodology to
normalize microarrays with an asymmetric representation
of modulated genes. We modelled this situation in the
analysis of the changes of gene expression in macrophages
following exposure to hypoxia. RNAs from control or
hypoxia-treated macrophage cell line were mixed with the
spikes and hybridized to our test-array. The 178 gene
expression results (Figure 8) were normalized using the
method described here that applied the loess algorithm
based on the spikes only (spike-in, blue line) or using the
loess applied to all genes (loess, green line) or the median
(median, red line) algorithm applied to all experimental
data without including the spikes' values. We used the
fold change of 1.3 as the threshold value to identify mod-
ulated genes as derived from the ROC curve analysis. We
found 25% of up-regulated, 19% of down-regulated and
56% of unchanged genes in response to hypoxia (Figure
8A) when the data were normalized with the spike-based
normalization. Similar results were obtained when the
median normalization algorithm and the loess based on
all genes were used. Furthermore, we plotted the fre-
quency of genes with increasing fold change values. Simi-
lar curves were obtained using the three methods of
normalization. These results demonstrated that the spike-
based normalization is interchangeable with global nor-
malization algorithms under condition in which the rep-
resentation of modulated and not modulated genes is
symmetric such as that shown in Figure 8A. The use of the
frequency of genes with the given fold change is a read out
of practical interesting that, however, is not suitable for
measuring the relative performance of the normalization
systems, based on assessment of relative biases and vari-
ances, that is thoroughly discussed in Park et al. [21].
Depending on the platform and on the aim of the analysis
some normalization may perform better than others, but
in our system with our read out we failed to appreciate sig-
nificant differences. However, different results were
obtained when we considered a case limit in which the
microarray contained only up-regulated genes. We mod-
elled this scenario by considering only the 45 genes up-
regulated identified in Figure 8A. The distribution of mod-
ulated genes on the bases of the three normalization
methods is shown in table of Figure 8B. The spike-based
normalization identified 100% of the inducible genes as
expected. In contrast, the median normalization algo-
rithm identified only 13% inducible genes because it
assumes a non-existing normal distribution of the data.
The majority of the genes were classified as not changed.
The loess normalization based on all genes generated
analogous results. Similar conclusions were drawn when
we plotted the frequency of genes with increasing fold
change. The spike-based normalization originated a curve
of frequency that had a similar slope as that observed in
Figure 8A indicating that this normalization can be
applied irrespectively to the symmetry of modulated
genes on the array. In contrast, the curve generated with
Detection limit of spiked RNA samples Figure 5
Detection limit of spiked RNA samples. 15 μg of total RNA 
were spiked with spike RNAs at increasing concentrations: 5 
pg, 10 pg, 50 pg, 100 pg, 250 pg, 500 pg, 1000 pg, 1500 pg, 
3000 pg and 5000 pg. The mean fluorescence intensity was 
plotted as a function of transcript concentration. The black 
line represents the linear regression calculated by the least 
squared method (R-squared = 0.9641).
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ROC curve for experiments leaded with known concentration of 8 spike genes Figure 6
ROC curve for experiments leaded with known concentration of 8 spike genes. The area under ROC curve gives an estimate 
of the test accuracy. In the table are reported sensitivity, specificity, and the proportion of correctly classified genes corre-
sponding to the expected ratios of 1, 1.5, 2, 3 and to the optimal thresholds of 1.26 and 1.74 provided by the ROC analysis.
Cut-off 1.00 1.26 1.50 1.74 2.00 3.00
Sensitivity (%) 99.1 89.7 82.6 82.0 81.4 66.9
Specificity (%) 50.0 97.8 98.9 99.6 100 100
Correctly classified (%) 77.7 93.3 89.7 89.7 89.6 81.4
1,0 0,8 0,6 0,4 0,2 0,0
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the median normalization algorithm and the loess based
on all genes failed to identify up-regulated genes indicat-
ing that these methods can not be applied to an asymmet-
ric distribution of genes such as that depicted in Figure 8B.
In conclusion, the spike system has a broader applicability
and is suitable for the analysis of asymmetric arrays
because it normalizes the results according to an external
reference independent from the experimental RNA and,
therefore, not affected by the symmetry of the array.
The genes that are up-regulated in macrophages by
hypoxia with a probability of 100% are listed in Table 5.
14 out of 17 genes are known to be up-regulated by
hypoxia or they have been validated by independent
assays including microarray with other platforms. In con-
trast, three genes were not previously associated with the
hypoxic response (F2r, Foxg1, Ifi204) and are currently
under investigation. These results confirm that we could
detect hypoxia inducible genes and that our platform is
MA-plots of the experimental genes (black dots) and of the spikes (represented with eight different colors) after loess normal- ization Figure 7
MA-plots of the experimental genes (black dots) and of the spikes (represented with eight different colors) after loess normal-
ization. The spikes are distributed around M = 0 and span about 75% of the range of log-intensity A.BMC Genomics 2007, 8:17 http://www.biomedcentral.com/1471-2164/8/17
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suitable for testing hypoxia diagnostic chips to be applied
to inflammatory diseases or cancer.
Conclusion
We describe the use of spike-in external control to nor-
malize a low-density microarray. The spikes are an exter-
nal reference that allows data normalization
independently from the expression of the experimental
RNA particularly suitable for situation in which there is
asymmetric distribution of modulated genes. This
approach does not rely upon the low-density property of
the array and, theoretically, it can be applied to high-den-
sity arrays. We can not exclude that the source of the
experimental RNA may affect the spike performance and
some evaluation of the parameters described here may be
needed in different experimental conditions. We demon-
strate that the application of loess normalization to the
spikes' signal decreases significantly the major source of
variability. Furthermore we introduce a criterion for the
removal of the outliers that is quite useful to further
reduce the system variability.
The choice of normalization method is critical for a cor-
rect interpretation of the results when the distribution of
the expression values in not symmetrical and/or the
number of spotted genes is limited. In fact, we show that
median normalization method or loess normalization
based on all genes spotted are unable to cope with situa-
tions in which only up-regulated genes are present on the
array. Unfortunately, the nature of the distribution of
gene expression is generally unknown and normalization
methods that are independent from this variable are desir-
able. We demonstrate that the spike-in method is as effec-
tive as other global normalization methods in dealing
with symmetric distribution of the expression values.
More important, we show that it can be successfully
applied also to situation in which the distribution of the
expression values is highly asymmetric. We conclude that
the spike-in system is a method of choice for arrays with a
potentially biased distribution. A situation in which there
is the potential for an asymmetric distribution is repre-
sented by low-density diagnostic chip where the choice of
the genes spotted may be deliberately biased towards
those that are up-regulated in a given pathological condi-
tion.
There is no reason to believe that the spike-in normaliza-
tion method could not be suitable for high-density micro-
arrays. The only possible technical limitation is the
inclusion of spike probes in commercially available chips.
However high-density microarrays are characterized by a
symmetric distribution and commonly used normaliza-
tion approaches are equally effective or possibly superior
as the intensity-dependant normalization procedure. A
thorough comparison among normalization methods has
been published [21].
We describe the use of eight spikes for an accurate normal-
ization of the platform and in our experience this condi-
tions allows an accurate normalization in every
experiment. On the basis of a Monte Carlo resampling
procedure we determined that theoretical minimum
number of five spikes each replicated 48 times is needed
for the normalization of our platform. However, such
number has severe limitations including the impossibility
of excluding the outliers. In general, the number of spikes
to be used in different applications may vary depending
on the stringency of the criteria used, on the desired vari-
ability threshold and on the robustness of the platform
and it may have to be recalibrated when using other
sources of RNA.
Our experimental system consists of RNA from cell line
cultured in normoxic condition or exposed to hypoxia, a
condition of low oxygen tension that characterizes several
pathological conditions. Very often, arbitrary expression
cut-offs are set to discriminate between genes that are
modulated or not changed. We describe here the success-
ful use of the ROC curves to assess objectively the thresh-
old to identify hypoxia-modulated genes. The expression
data obtained with our platform are consistent with previ-
ous information generated in our laboratory using other
platforms and with the data in the literature relative to the
response of macrophages to hypoxia confirming that we
could detected hypoxia inducible genes and that our plat-
form is suitable for supporting hypoxia diagnostic chips.
In summary, we present an accurate description and char-
acterization of a normalization procedure of a low-density
microarray based on spike in external controls that has the
potential of a broad applicability to different types of
arrays including those in which there is an asymmetric
distribution of the up/down-regulated genes.
Methods
Microarray fabrication
C6-amino-linker oligonucleotides (50 nucleotides in
length) were obtained from MWG oligoset (MWG-Bio-
tech AG, Ebersberg, Germany), and spike-in controls oli-
gonucleotides were purchased from Ambion
ArrayControl Spot (Ambion Inc., Austin TX). Oligonucle-
otides were printed on e-Surf Activated Slides (Life Line
Lab S.r.l., Italy) with a SpottingArray 24 (PerkinElmer,
Wellesley, MA) using 4 Stealth Micro Spotting Pins (Tel-
echem International, Inc. Sunnyvale, CA) in 150 mM
phosphate buffer pH 8,5 at 40% humidity. E-surf acti-
vated slides are obtained by adsorption on glass of a
hydrophilic polymer containing N, Nacryloyloxysuccin-
imide (NAS). Oligonucleotides were printed at a finalBMC Genomics 2007, 8:17 http://www.biomedcentral.com/1471-2164/8/17
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Effect of different normalization procedures on the detection of modulated genes Figure 8
Effect of different normalization procedures on the detection of modulated genes. RNAs from control or hypoxia -treated 
macrophage cell line were mixed with the spikes and hybridized to our test-array. Data were filtered (including the outliers 
removal), normalized with spike-in method (blue line), with the median (red line) or with the loess based on all genes (green 
line) and scaled. The graphs plot the percentage of genes (Y-axis) having a value equal or greater than that indicated in the X-
axis. (A) The analysis was carried on the entire test-array comprising 178 genes symmetrically distributed in up-regulated, 
down-regulated and not modulated. (B) The analysis was carried on 45 genes having a fold change equal or greater than 1.3 
and representing an asymmetric distribution.
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concentration of 10 pmol/μl. The coupling reaction was
performed o/n in a saturated NaCl solution chamber with
a 75% relative humidity. All oligonucleotides were
printed in quadruplicates over 4 subarrays with a 2 × 2
print head. Spike-in controls oligonucleotides, negative
control and buffer were printed in quadruplicates onto
each subarray. The scheme is repeated 3 times on the
entire slide surface resulting in 12 replicates for each gene
element and 48 replicates for each control element.
RNA preparation
ANA-1 cell line [15] was cultured and maintained at 37°C
in a humidified incubator containing 20% O2, 5% CO2
and 75% N2. For hypoxic conditions, cells were incubated
in a humidified anaerobic workstation incubator (BUG
BOX, Ruskinn, UK) flushed with a mixture of 94% N2,
5% CO2 and 1%O2. Total RNA was extracted from ANA-
1 cells grown under normoxic or hypoxic conditions for
18 hours, using Trizol (Invitrogen Life technologies,
Irvine, CA) according to the manufacturer's protocol. The
physical quality control of RNA integrity was carried out
by electrophoresis using Agilent Bioanalyzer 2100 (Agi-
lent Technologies, Waldbronn, Germany) and quantified
by NanoDrop (NanoDrop Technologies, Wilmington,
Delaware USA). Spike-in controls RNA were purchased
from Ambion ArrayControl RNA Spikes. The RNA Spikes
are a set of 8 purified RNA transcripts with sequence
homology to the corresponding ArrayControl Spot. The
ArrayControl sequences were selected from Escherichia
coli genes that show no sequence similarity to mamma-
lian genomes.
Sample labeling and microarray hybridization
15 μg of total RNA were converted in either Cy3- or Cy5-
labeled cDNA probe using the Superscript indirect cDNA
labelling kit (Invitrogen Life technologies, Irvine, CA).
Spike RNA were added in appropriately diluted 2 μl mix-
ture to total RNA and to oligodT primer, RNase-free water
was used to bring the volume to 18 μl, and the reaction
was denatured at 70° for 5 min and then chilled on ice.
Amminoallyl-modified cDNA was generated in the pres-
ence of 5× first-strand buffer, 0.1 M DTT, dNTP mix
(including amino-modified nucleotides), RNaseOUT™
(40 U/μl), SuperScript™ III RT (400 U/μl) in a final vol-
ume of 30 μl at 46°C for 3 hours. RNA template was
hydrolyzed by the addition of 15 μl of 1 N NaOH fol-
lowed by heating at 70°C for 10 min. Reactions were neu-
tralized with 15 μl of 1 N HCl, and cDNA was purified on
S.N.A.P. columns according to the manufacturer's instruc-
tions followed by ethanol precipitation. cDNA was
lyophilized to dryness and resuspended in 5 μl of 2× cou-
pling buffer. NHS ester of Cy3 or Cy5 dye (Amersham
Pharmacia, GE Healthcare Little Chalfont, UK) in DMSO
(dye from one tube was dissolved in 5 μl of DMSO) were
added and reactions were incubated at room temperature
in the dark for 1 h. Coupling reactions were quenched by
the addition of 20 μl of 3 M sodium acetate pH 5.2, and
unincorporated dye was removed using S.N.A.P. columns.
The combined Cy3 and Cy5 probes were dried down in a
speed-vac and then dissolved in 6 μl of RNase-free water.
10 μg of Cot-1 DNA, 10 μg of poly(A) and 4 μg of yeast
tRNA were added, the mixture was denatured at 95°C for
3 min and then cooled down on ice for 1 min. 35% for-
Table 5: list of up-regulated genes
Gene name GeneBanka) Description Fold changeb) Referencesc)
Vegfa NM_009505 Vascular endothelial growth factor A 3.66 [11]
Selenbp1 NM_009150 Selenium binding protein 1 2.98 unpublished
Gna13 NM_010303 Guanine nucleotide binding protein, alpha 13 2.92 unpublished
Anxa4 NM_013471 Annexin A4 2.89 [11]
Bsg AK002332 Basigin 2.62 [28]
F2r NM_010169 Coagulation factor II (thrombin) receptor 2.60
P4hb X06453 Prolyl 4-hydroxylase, beta polypeptide 2.23 [28]
G3pdh NM_008084 Glyceraldehyde-3-phosphate dehydrogenase 2.07 [29]
Bnip3l NM_009761 BCL2/adenovirus E1B interact protein 3-like 2.00 [30]
Foxg1 NM_008241 Forkhead box G1 1.97
Ifi204 NM_008329 Interferon-inducible protein p204 1.96
Ctsd NM_009983 Cathepsin D 1.95 [31]
Btg1 L16846 B-cell translocation gene 1 1.93 [32]
Es10 NM_016903 Esterase 10 1.83 unpublished
Ecm1 NM_007899 Extracellular matrix protein 1 1.79 unpublished
Cxcr4 AB000803 Chemokine (C-X-C motif) receptor 4 1.77 [33]
Il15 NM_008357 Interleukin 15 1.76 unpublished
a) GeneBank accession number. b) The indicated values represent the ratio of hypoxic/normoxic signals (mean of 4 experiments). c) Genes validated 
in published literature or by our unpublished observation using independent mRNA assessment methods.BMC Genomics 2007, 8:17 http://www.biomedcentral.com/1471-2164/8/17
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mamide, 3.5× SSC, 0.3% SDS and 2.5× Denhardt's were
added to a final volume of 90 μl. Slides were blocked in
an appropriate blocking solution, 100 mM ethanolamine,
0.2 M Tris, pH 9.0, at 50°C for 20 min and then washed
in 4× SSC, 0.1% SDS for 20 min. Blocked slides were pre-
hybridized at 42°C for 45 minutes with a pre-hybridiza-
tion mixture (35% formamide, 4× SSC, 0.5% SDS, 2.5×
Denhardt's, 20 ng/μl Salmon Sperm DNA) in the HS 400
hybridization station (Tecan Austria GmbH, Salzburg,
Austria). Hybridizations were carried out at 42°C for 16 h
automatically agitated every 5 min, followed by washing
in (3 min each): 2× SSC and 0.1% SDS, 1× SSC and 0.5×
SSC at room temperature.
Data acquisition, normalization and analysis
Arrays were scanned using a GenePix 4000B dual-color
confocal laser scanner (Axon Instruments, Union City,
CA) at 10-micron resolution. Images were processed, and
signals from spotted arrays were quantitated using Gene-
Pix Pro 5.1 software (Axon Instruments). Array images
that did not pass minimal quality control were discarded
(median signal-to-background >3; median signal-to noise
>3; mean of median background signal <200). Techni-
cally imperfect spots were removed either automatically
by the GenePix software or through manual investigation
of the array images. Such spots were flagged as 'absent' in
the GenePix results files and they were not included in the
analysis. To discard data from weak signals, spots with
<50% of pixels >2 SD above median local background sig-
nal were flagged 'absent' too. Data from spots that not
passed this criterion for one channel but with >95% of the
pixels >2 SD above median local background signal in the
other channel were kept. GenePix result files, including
signal, background, standard deviation, pixel statistics
and quality parameters on both channels have been
imported in the statistical environment R [22] using Bio-
conductor software [23] for the subsequent normalization
process. Background-subtracted fluorescence log-ratios
were normalized within each array by using composite
loess normalization [14] available in the Bioconductor
package limma [23,24]. Composite loess normalization
corrects the expression log-ratios for intensity-based
trends subtracting from each expression log-ratio the cor-
responding value of the loess curve. The loess curve is con-
structed by performing a series of local regressions, one
local regression for each spike-in control spot on the cor-
responding MA-plot [13]. Being R and G, the background-
corrected red and green intensities for each spot, the
expression log-ratio (M-value) corresponding to a spot is
M = log2R - log2G, whereas the log-intensity (A-value) of
each spot is defined as A = (log2R+log2G)/2, a measure of
the overall brightness of the spot. All spike-in control
spots (after filtering) have been included in each local esti-
mate of the loess curve (this corresponds to set the param-
eter span equal to 1 in the implementation of the loess
normalization algorithm in the package limma) to avoid
a non-reliable representation of the overall trend within
the sliding windows used for local regressions due to the
low number of genes spotted on the array. Median percen-
tile normalization was performed utilizing the "normalize
to median or percentile" option in GeneSpring GX 7.3
(Silicon Genetics, Redwood City, CA).
In some cases, loess normalized M-values have also been
scaled across a series of arrays. The need for scaling across
arrays has been determined empirically in each instance,
according to the experimental evidences on different
classes of spots (basically, spike and non-spike genes). We
used two different methods for scaling, both imple-
mented in the package limma: the scale method [3,5,14],
whose basic idea is simply to scale the M-values to have
the same median-absolute-deviation (MAD) across arrays;
and the quantile method [19], which ensures that the M-
values have the same empirical distribution across arrays
and across channels.
Analysis of variance (ANOVA)
Analysis of variance (ANOVA) is a procedure for con-
structing statistical tests by partitioning the total variance
into different sources. ANOVA model consists in a separa-
tion of a complex variance term into its components [25].
We create a fixed effect model with interaction terms to
evaluate the main effects of the potential sources of vari-
ance. To confirm the loess normalization we performed
ANOVA among data before and after the normalization
process. The ANOVA model is:
logR(g, d, s) = μ+G(g)+D(d)+S(s)+GD(gd)+ ε(g, d, s)
where log R(gds) is the measured log ratio for spike g, con-
centration d, and array position s; μ is the average log ratio
over the whole array, G(g) is main effect for spike charac-
teristics, D(d) is the main effect for the spike RNA amount
(concentration), S(s) is main effect for position on the
array, GD(gd) is a term accounting for effects of the inter-
action between the spike characteristics and the concen-
tration and ε(g, d, s) is stochastic error. The error is
assumed to be independent and of zero mean. To satisfy
these assumptions, the homogeneity of the variances was
visually inspected by residual graphic analysis. Statistical
analysis was performed with SPSS 13.0 (SSPS Inc., Chi-
cago, IL).
ROC analysis
System specificity and sensitivity in detecting differential
gene expression were evaluated using receiver operating
characteristic (ROC) curves [26]. A ROC curve shows the
relationship between the proportion of true positive (Sen-
sitivity) and false positive (1-Specificity) classifications
resulting from each possible decision threshold value in aBMC Genomics 2007, 8:17 http://www.biomedcentral.com/1471-2164/8/17
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two-class classification task [20]. The area under the curve
is a measure of test accuracy [27], and when applied to a
gene expression profile, it provides an estimate of the
probability that a gene is up- or down-regulated in a given
group. The spike RNAs were added to the hybridization
mixture of the arrays at pre-determined specific concentra-
tions ranging from 500 to 1500 pg. Test sensitivity was
calculated as the number of regulated genes correctly clas-
sified by the test divided by the number of regulated
genes. False-positive rate is defined as the number of false
positives genes from the group of non-regulated genes
divided by the total number of non-regulated genes. Sta-
tistical analysis was performed with STATA 8.0 (StataCorp
LP, College Station, TX).
Description of experiments
All microarray raw data were provided as additional files.
We performed three types of microarray experiments. (i)
In dilution experiments all the spike RNAs were added in
the same quantity in both channels. We set up four differ-
ent dilutions: 10 pg (additional file 1), 250 pg, 750 pg
(additional file 2) and 1000 pg (additional file 3). The
experiment at 250 pg was performed in quadruplicate
(additional files 4, 5, 6, 7). Data from these dilution
experiments were used for Figure 1, Figure 2, Figure 3, Fig-
ure 4, Figure 7, Figure 8, Table 2, Table 3, Table 4 and
Table 5. (ii) In range experiments two different mixtures
were set up to cover a wide range of signal intensity. Every
spike RNA was added in the same quantity in both chan-
nels to get a final ratio of 1, but in the same mixture the
spikes were present at increasing concentrations. Mix 1
contains spikes at 5 pg, 10 pg, 50 pg, 100 pg, 500 pg and
1000 pg (additional file 8). Mix 2 contains spikes at 250
pg, 500 pg, 1000 pg, 1500 pg, 3000 pg and 5000 pg (addi-
tional file 9). Data from range experiments were used for
data in Figure 5. (iii) ROC experiments were planned to
compare expected with measured signal ratios. The spike
RNAs were added in defined quantity to obtain ratios of 1
(500/500 pg), 1.5 (750/500 pg), 2 (1000/500 pg) and 3
(1500/500 pg) (additional file 10). Dye swap was per-
formed to get reverse ratios (additional file 11). Data from
ROC experiments were used in Figure 6.
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Additional File 1
Microarray raw data of the10 pg dilution experiment. All the spike RNAs 
were added at the same quantity in both channels.
Click here for file
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Additional File 2
Microarray raw data of the 750 pg dilution experiment. All the spike 
RNAs were added at the same quantity in both channels.
Click here for file
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Additional File 3
Microarray raw data of the1000 pg dilution experiment. All the spike 
RNAs were added at the same quantity in both channels.
Click here for file
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2164-8-17-S3.xls]
Additional File 4
Microarray raw data of the 250 pg dilution experiment, replicate A. All 
the spike RNAs were added at the same quantity in both channels.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-17-S4.xls]
Additional File 5
Microarray raw data of the 250 pg dilution experiment, replicate B. All 
the spike RNAs were added at the same quantity in both channels.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-17-S5.xls]
Additional File 6
Microarray raw data of the 250 pg dilution experiment, replicate C. All 
the spike RNAs were added at the same quantity in both channels.
Click here for file
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2164-8-17-S6.xls]
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Microarray raw data of the 250 pg dilution experiment, replicate D. All 
the spike RNAs were added at the same quantity in both channels.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-17-S7.xls]
Additional File 8
Microarray raw data of the mix 1 range experiment. Every spike RNA was 
added in the same quantity in both channels to get a final ratio of 1, but 
in the same mixture the spikes were present at increasing concentrations: 
sp1: 1000 pg; sp2: 500 pg; sp3: 5 pg; sp4: 10 pg; sp5: 1000 pg; sp6: 500 
pg: sp7: 50 pg; sp8: 100 pg.
Click here for file
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